Xylaric acid

Details

Top
Internal ID 342a574a-4992-4f41-9d23-da5b2a5de27d
Taxonomy Organoheterocyclic compounds > Pyrans > Pyranones and derivatives
IUPAC Name 2-(4-oxopyran-3-yl)acetic acid
SMILES (Canonical) C1=COC=C(C1=O)CC(=O)O
SMILES (Isomeric) C1=COC=C(C1=O)CC(=O)O
InChI InChI=1S/C7H6O4/c8-6-1-2-11-4-5(6)3-7(9)10/h1-2,4H,3H2,(H,9,10)
InChI Key OIYFAQRHWMVENL-UHFFFAOYSA-N
Popularity 9 references in papers

Physical and Chemical Properties

Top
Molecular Formula C7H6O4
Molecular Weight 154.12 g/mol
Exact Mass 154.02660867 g/mol
Topological Polar Surface Area (TPSA) 63.60 Ų
XlogP -0.40
Atomic LogP (AlogP) 0.27
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
10158-64-2
SCHEMBL3657249
4-oxo-4h-pyran-3-acetic acid
OIYFAQRHWMVENL-UHFFFAOYSA-
DTXSID30144027
C5-H8-O7
(4-Oxo-4H-pyran-3-yl)-acetic acid
L-741494
InChI=1/C7H6O4/c8-6-1-2-11-4-5(6)3-7(9)10/h1-2,4H,3H2,(H,9,10)

2D Structure

Top
2D Structure of Xylaric acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9370 93.70%
Caco-2 + 0.7585 75.85%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability + 0.7857 78.57%
Subcellular localzation Mitochondria 0.8429 84.29%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8824 88.24%
OATP1B3 inhibitior + 0.9590 95.90%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9765 97.65%
P-glycoprotein inhibitior - 0.9895 98.95%
P-glycoprotein substrate - 0.9821 98.21%
CYP3A4 substrate - 0.7363 73.63%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8714 87.14%
CYP3A4 inhibition - 0.9283 92.83%
CYP2C9 inhibition - 0.9325 93.25%
CYP2C19 inhibition - 0.9609 96.09%
CYP2D6 inhibition - 0.9532 95.32%
CYP1A2 inhibition - 0.9818 98.18%
CYP2C8 inhibition - 0.9485 94.85%
CYP inhibitory promiscuity - 0.9779 97.79%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8528 85.28%
Carcinogenicity (trinary) Non-required 0.7375 73.75%
Eye corrosion - 0.8857 88.57%
Eye irritation + 0.9930 99.30%
Skin irritation + 0.6625 66.25%
Skin corrosion - 0.9402 94.02%
Ames mutagenesis - 0.7200 72.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8575 85.75%
Micronuclear + 0.6535 65.35%
Hepatotoxicity + 0.6908 69.08%
skin sensitisation - 0.6642 66.42%
Respiratory toxicity + 0.5222 52.22%
Reproductive toxicity + 0.6222 62.22%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity - 0.5886 58.86%
Acute Oral Toxicity (c) II 0.4345 43.45%
Estrogen receptor binding - 0.9746 97.46%
Androgen receptor binding - 0.8580 85.80%
Thyroid receptor binding - 0.8888 88.88%
Glucocorticoid receptor binding - 0.9319 93.19%
Aromatase binding - 0.8809 88.09%
PPAR gamma - 0.6531 65.31%
Honey bee toxicity - 0.9829 98.29%
Biodegradation + 0.7750 77.50%
Crustacea aquatic toxicity - 0.9100 91.00%
Fish aquatic toxicity - 0.3694 36.94%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.57% 91.11%
CHEMBL2581 P07339 Cathepsin D 89.46% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.97% 95.56%
CHEMBL221 P23219 Cyclooxygenase-1 84.26% 90.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.15% 85.14%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.47% 86.33%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.27% 94.45%

Cross-Links

Top
PubChem 3084064
NPASS NPC174513
LOTUS LTS0268377
wikiData Q77564477